Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1998-09-28
1999-11-30
Clardy, S. Mark
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 111, 424 165, 530300, 530326, 534 10, 534 14, A61K 5100, A61M 3614
Patent
active
059937750
ABSTRACT:
The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m, rhenium-186, or rhenium-188 and which can be targeted to specific sites within a mammalian body.
REFERENCES:
patent: 4986979 (1991-01-01), Morgan
patent: 5443815 (1995-08-01), Dean
patent: 5561220 (1996-10-01), Dean
patent: 5670133 (1997-09-01), Zamora
patent: 5736122 (1998-04-01), Dean et al.
patent: 5807537 (1998-09-01), Dean
patent: 5814297 (1998-09-01), Dean et al.
patent: 5866097 (1999-02-01), Dean et al.
patent: 5879658 (1999-03-01), Dean et al.
Deutsch, et al, (1986) "The Chemistry of Rhenium and Technetium as Related to the Use of Isotopes of these Elements in Therapeutic and Diagnostic Nuclear Medicine," Nucl. Med. Biol., 13, 465-477.
Clardy S. Mark
Diatide, Inc.
Jones Dameron
McDaniels Patricia A.
LandOfFree
Radioactively labeled peptides comprising a single thiol moiety does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioactively labeled peptides comprising a single thiol moiety, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactively labeled peptides comprising a single thiol moiety will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1667880